Deferred Tax Assets, Valuation Allowance of ZEVRA THERAPEUTICS, INC. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ZEVRA THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • ZEVRA THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $91,498,000, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $91,498,000 -$54,861,000 -37% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $146,359,000 +$11,871,000 +8.8% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $134,488,000 +$52,657,000 +64% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q4 2022 $81,831,000 +$9,320,000 +13% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $72,511,000 +$2,419,000 +3.5% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q4 2020 $70,092,000 +$2,906,000 +4.3% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $67,186,000 +$6,994,000 +12% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $60,192,000 +$17,227,000 +40% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q4 2017 $42,965,000 -$5,811,000 -12% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q4 2016 $48,776,000 +$19,753,000 +68% 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q4 2015 $29,023,000 +$10,927,000 +60% 31 Dec 2015 10-K 30 Mar 2018 2017 FY
Q4 2014 $18,096,000 +$7,691,000 +74% 31 Dec 2014 10-K 10 Mar 2017 2016 FY
Q4 2013 $10,405,000 31 Dec 2013 10-K 16 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.